The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 08, 2025

Filed:

Feb. 28, 2024
Applicant:

Alnylam Pharmaceuticals, Inc., Cambridge, MA (US);

Inventors:

Martin Maier, Cambridge, MA (US);

Muthusamy Jayaraman, Cambridge, MA (US);

Akin Akinc, Cambridge, MA (US);

Shigeo Matsuda, Cambridge, MA (US);

Pachamuthu Kandasamy, Cambridge, MA (US);

Kallanthottathil G. Rajeev, Cambridge, MA (US);

Muthiah Manoharan, Cambridge, MA (US);

Jayaprakash K. Nair, Cambridge, MA (US);

Thomas A. Baillie, Cambridge, MA (US);

Assignee:

ALNYLAM PHARMACEUTICALS, INC., Cambridge, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/18 (2017.01); A61K 9/1272 (2025.01); A61K 9/51 (2006.01); A61K 31/7088 (2006.01); A61K 31/7105 (2006.01); A61K 31/713 (2006.01); C07C 31/125 (2006.01); C07C 211/09 (2006.01); C07C 211/10 (2006.01); C07C 211/11 (2006.01); C07C 217/08 (2006.01); C07C 229/12 (2006.01); C07C 235/06 (2006.01); C07C 251/38 (2006.01); C07C 323/12 (2006.01); C07C 323/58 (2006.01); C07C 327/22 (2006.01); C07C 327/28 (2006.01); C07C 327/32 (2006.01); C07D 207/32 (2006.01); C07D 233/54 (2006.01); C07D 295/08 (2006.01); C07D 295/12 (2006.01); C07D 295/14 (2006.01); C07D 317/30 (2006.01); C07F 5/02 (2006.01);
U.S. Cl.
CPC ...
A61K 47/18 (2013.01); A61K 9/1272 (2013.01); A61K 9/5123 (2013.01); A61K 31/7088 (2013.01); A61K 31/7105 (2013.01); A61K 31/713 (2013.01); C07C 31/125 (2013.01); C07C 211/09 (2013.01); C07C 211/10 (2013.01); C07C 211/11 (2013.01); C07C 217/08 (2013.01); C07C 229/12 (2013.01); C07C 235/06 (2013.01); C07C 251/38 (2013.01); C07C 323/12 (2013.01); C07C 323/58 (2013.01); C07C 327/22 (2013.01); C07C 327/28 (2013.01); C07C 327/32 (2013.01); C07D 207/32 (2013.01); C07D 233/54 (2013.01); C07D 295/08 (2013.01); C07D 295/12 (2013.01); C07D 295/14 (2013.01); C07D 317/30 (2013.01); C07F 5/022 (2013.01);
Abstract

The present invention relates to a cationic lipid having one or more biodegradable groups located in a lipidic moiety (e.g., a hydrophobic chain) of the cationic lipid. These cationic lipids may be incorporated into a lipid particle for delivering an active agent, such as a nucleic acid. The invention also relates to lipid particles comprising a neutral lipid, a lipid capable of reducing aggregation, a cationic lipid of the present invention, and optionally, a sterol. The lipid particle may further include a therapeutic agent such as a nucleic acid.


Find Patent Forward Citations

Loading…